MYNAVCARE PATIENT SUPPORT BY GENMAB
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97936715
- Registration number
- 7819912
- Mark type
- Stylized text
- Filed
- 15 May 2023
- Published for opposition
- 19 Mar 2024
- Registered
- 03 Jun 2025
- Attorney of record
- Max Vern
Goods and services
- Class 035 — Advertising and business services: Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
- Class 036 — Insurance and financial services: Financial administration of patient reimbursement and patient financial assistance programs, namely, reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
- Class 044 — Medical, beauty and agricultural services: Medical assistance, namely, disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
- Class 045 — Legal and security services: Providing personal support services for patients and families of patients in connection to disease management and navigation through medical treatments, namely, emotional counseling and emotional support; Providing personal support services for families of patients with life threatening disorders in connection to disease management and reimbursement of medical expenses, namely, companionship, help with medical forms, emotional counseling and emotional support; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries
Owner
- Genmab A/S, Valby, DK
- Genmab A/S, Valby, DK
- Genmab A/S, Valby, DK
Prosecution history
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Apr 2025 — ASSIGNED TO LIE
- 08 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Feb 2025 — NON-FINAL ACTION E-MAILED
- 13 Feb 2025 — SU - NON-FINAL ACTION - WRITTEN
- 23 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Nov 2024 — USE AMENDMENT FILED
- 22 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 07 Nov 2024 — TEAS STATEMENT OF USE RECEIVED